[HTML][HTML] Direct oral anticoagulant plasma levels' striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona …

S Testa, P Prandoni, O Paoletti, R Morandini… - Journal of Thrombosis …, 2020 - Elsevier
Background Antiviral drugs are administered in patients with severe COVID‐19 respiratory
syndrome, including those treated with direct oral anticoagulants (DOACs). Concomitant …

[HTML][HTML] Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants

…, B Cosmi, V Pengo, D Poli, R Morandini… - Journal of Thrombosis …, 2019 - Elsevier
Essentials • Currently, DOACs are given at fixed doses and do not require laboratory monitoring.
• Direct oral anticoagulant‐specific measurements were performed at trough and peak. …

[HTML][HTML] Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study

…, F De Gennaro, AL Nardecchia, R Morandini… - Internal and Emergency …, 2020 - Springer
The association between coronavirus disease 2019 (COVID-19) pneumonia and venous
thrombotic disorders is still unclear. We assessed the association between COVID-19 infection-…

[HTML][HTML] Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry

S Testa, W Ageno, E Antonucci, R Morandini… - Internal and emergency …, 2018 - Springer
The management of major bleeding in patients treated with direct oral anticoagulants (DOACs)
is still not well established. START-Events, a branch of the START registry (Survey on …

[HTML][HTML] COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence

…, MI Tassoni, G Carolla, M Tala, R Morandini… - Blood …, 2020 - ncbi.nlm.nih.gov
Over the past four months, COVID-19, the disease associated with the severe acute respiratory
syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan and the Hubei province of …

Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

…, A Ciampa, E Antonucci, D Poli, R Morandini… - Blood …, 2024 - ashpublications.org
Although effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …

Edoxaban plasma levels in patients with non-valvular atrial fibrillation: Inter and intra-individual variability, correlation with coagulation screening test and renal …

…, C Dellanoce, O Paoletti, E Cancellieri, R Morandini… - Thrombosis …, 2019 - Elsevier
Background High inter-individual variability of the anticoagulant plasma levels of the first
three direct oral anticoagulants was previously reported. Aims of the present study were to …

The effect of management models on thromboembolic and bleeding rates in anticoagulated patients: an ecological study

…, O Paoletti, I Nichele, F Catalano, R Morandini… - Internal and Emergency …, 2019 - Springer
The primary study objective is to compare the outcomes of patients taking oral anticoagulant
medications in two distinct populations treated according to different management models (…

Cellavision DM-96: white blood cell morphological evaluation and platelet count

M Tala, O Paoletti, MA Medagliani, R Morandini… - La Rivista Italiana della …, 2015 - Springer
Premesse. L’impiego di contaglobuli automatici per il conteggio dei globuli bianchi (WBC),
globuli rossi (RBC) e piastrine (PLT) rappresenta ormai il sistema di analisi più diffuso nei …

[PDF][PDF] Valutazione del sistema Cellavision DM-96 nell'analisi della formula leucocitaria e nel conteggio piastrinico

…, O Paoletti, MA Medagliani, R Morandini… - La Rivista Italiana …, 2015 - researchgate.net
Premesse. L’impiego di contaglobuli automatici per il conteggio dei globuli bianchi (WBC),
globuli rossi (RBC) e piastrine (PLT) rappresenta ormai il sistema di analisi più diffuso nei …